BioSpace News Archive

Drug Development

XOMA (US) LLC Initiates Pilot Trial Studying Gevokizumab in Patients With Pyoderma Gangrenosum

June 13, 2013
·
1 min read
Drug Development

Immunomedics, Inc. Reports That UCB Group Announces New Results From Phase 2B Open-Label Extension Study Evaluating the Long-Term Effects of Epratuzumab in SLE

June 13, 2013
·
1 min read
Lombard Medical Technologies: Result of Offer

June 13, 2013
·
2 min read
Business

Oasmia Appoints New Vice President Communications

June 13, 2013
·
1 min read
Drug Development

Data and Safety Monitoring Board Recommends Continuation of Sunesis Pharmaceuticals, Inc.’ VALOR Trial With No Change to Study Conduct

June 13, 2013
·
1 min read
Biotech Bay

Sunesis Pharmaceuticals, Inc. to Present at the Wells Fargo 2013 Healthcare Conference

June 13, 2013
·
1 min read
Drug Development

As the First Biopharmaceutical Company Worldwide, Apceth GmbH Receives Approval for a Clinical Trial With Genetically Modified Adult Mesenchymal Stem Cells for the Treatment of Cancer

June 13, 2013
·
3 min read
Drug Development

Epizyme Enrolls First Patient in Phase 1/2 Clinical Trial of EPZ-6438, an Inhibitor of EZH2

June 13, 2013
·
1 min read
Pharm Country

Celsion Corporation Issues Statement Regarding Misleading Blog Entry

June 13, 2013
·
4 min read
Drug Development

Janssen Research & Development Release: STELARA® Phase 3 Study Published in the Lancet Reports One Year Efficacy and Safety in Treatment of Active Psoriatic Arthritis

June 13, 2013
·
13 min read